Sanjiv Modi

760 total citations
11 papers, 589 citations indexed

About

Sanjiv Modi is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Sanjiv Modi has authored 11 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Sanjiv Modi's work include Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Hematopoietic Stem Cell Transplantation (2 papers). Sanjiv Modi is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Hematopoietic Stem Cell Transplantation (2 papers). Sanjiv Modi collaborates with scholars based in United States, Canada and Germany. Sanjiv Modi's co-authors include C. L. Beach, Thomas M. Cosgriff, Jay T. Backstrom, Heidi McIntyre, Roger M. Lyons, John D. Hainsworth, Allen Lee Cohn, Robert H. Gersh, Everett E. Vokes and Janet Dancey and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Sanjiv Modi

11 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanjiv Modi United States 8 245 242 210 183 161 11 589
Nicholas Burwick United States 15 393 1.6× 313 1.3× 171 0.8× 245 1.3× 173 1.1× 36 753
Yuji Shimura Japan 15 357 1.5× 227 0.9× 226 1.1× 100 0.5× 199 1.2× 69 704
Stéphanie Struski France 16 264 1.1× 171 0.7× 112 0.5× 134 0.7× 94 0.6× 30 596
Yoshiaki Chinen Japan 14 291 1.2× 170 0.7× 143 0.7× 58 0.3× 134 0.8× 49 513
Guillermo Martín–Núñez Spain 13 416 1.7× 572 2.4× 248 1.2× 289 1.6× 103 0.6× 26 822
Sophie Derenne France 8 418 1.7× 338 1.4× 362 1.7× 59 0.3× 88 0.5× 11 780
Domenica Gandini United States 14 293 1.2× 299 1.2× 142 0.7× 116 0.6× 147 0.9× 23 691
Chung Hoow Kok Australia 17 338 1.4× 454 1.9× 153 0.7× 245 1.3× 74 0.5× 68 800
Xiangao Huang United States 12 401 1.6× 193 0.8× 382 1.8× 325 1.8× 311 1.9× 40 873
Fei Fei United States 14 227 0.9× 229 0.9× 241 1.1× 113 0.6× 43 0.3× 46 654

Countries citing papers authored by Sanjiv Modi

Since Specialization
Citations

This map shows the geographic impact of Sanjiv Modi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjiv Modi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjiv Modi more than expected).

Fields of papers citing papers by Sanjiv Modi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanjiv Modi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjiv Modi. The network helps show where Sanjiv Modi may publish in the future.

Co-authorship network of co-authors of Sanjiv Modi

This figure shows the co-authorship network connecting the top 25 collaborators of Sanjiv Modi. A scholar is included among the top collaborators of Sanjiv Modi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjiv Modi. Sanjiv Modi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Stadler, Walter M., David J. Vaughn, Guru Sonpavde, et al.. (2013). An open‐label, single‐arm, phase 2 trial of the polo‐like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer. Cancer. 120(7). 976–982. 80 indexed citations
2.
Sharma, Manish, Kristen Wroblewski, Blasé N. Polite, et al.. (2011). Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium. Investigational New Drugs. 30(3). 1211–1215. 43 indexed citations
3.
Smith, Sonali M., Koen van Besien, Theodore Karrison, et al.. (2010). Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium. Journal of Clinical Oncology. 28(31). 4740–4746. 165 indexed citations
4.
Lyons, Roger M., Thomas M. Cosgriff, Sanjiv Modi, et al.. (2009). Hematologic Response to Three Alternative Dosing Schedules of Azacitidine in Patients With Myelodysplastic Syndromes. Journal of Clinical Oncology. 27(11). 1850–1856. 199 indexed citations
5.
Lyons, Roger M., Thomas M. Cosgriff, Sanjiv Modi, et al.. (2007). Results of the Initial Treatment Phase of a Study of Three Alternative Dosing Schedules of Azacitidine (Vidaza®) in Patients with Myelodysplastic Syndromes (MDS).. Blood. 110(11). 819–819. 11 indexed citations
6.
Smith, Sonali M., Barbara Pro, Scott E. Smith, et al.. (2006). Molecular Inhibition of mTOR with Temsirolimus (TORISEL™, CCI-779) Is a Promising Strategy in Relapsed NHL: The University of Chicago Phase II Consortium.. Blood. 108(11). 2483–2483. 6 indexed citations
7.
Lyons, Roger M., Thomas M. Cosgriff, Sanjiv Modi, et al.. (2006). Hematologic Improvement, Transfusion Independence, and Safety Assessed Using Three Alternative Dosing Schedules of Azacitidine in Patients with Myelodysplastic Syndromes.. Blood. 108(11). 2662–2662. 2 indexed citations
8.
9.
Alsayed, Yazan, Sanjiv Modi, Shahab Uddin, et al.. (2000). All-trans-retinoic acid induces tyrosine phosphorylation of the CrkL adapter in acute promyelocytic leukemia cells. Experimental Hematology. 28(7). 826–832. 8 indexed citations
10.
Uddin, Shahab, et al.. (2000). Interferon-Dependent Activation of the Serine Kinase PI 3′-Kinase Requires Engagement of the IRS Pathway but Not the Stat Pathway. Biochemical and Biophysical Research Communications. 270(1). 158–162. 57 indexed citations
11.
Chen, Yi-Hsiang, et al.. (1997). Modulation of Interleukin-6/Interleukin-6 Receptor Cytokine Loop in the Treatment of Multiple Myeloma. Leukemia & lymphoma. 27(1-2). 11–23. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicholas Burwick Breakdown of academic impact, for papers by Yuji Shimura Breakdown of academic impact, for papers by Stéphanie Struski Breakdown of academic impact, for papers by Yoshiaki Chinen Breakdown of academic impact, for papers by Guillermo Martín–Núñez Breakdown of academic impact, for papers by Sophie Derenne Breakdown of academic impact, for papers by Domenica Gandini Breakdown of academic impact, for papers by Chung Hoow Kok Breakdown of academic impact, for papers by Xiangao Huang Breakdown of academic impact, for papers by Fei Fei
Rankless by CCL
2026